Ubs Asset Management Americas Inc Generation Bio Co. Transaction History

Ubs Asset Management Americas Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.99 - $24.97 $2,941 - $12,260	-491 Reduced 1.95%	24,668 $174,000
Q3 2021 Nov 15, 2021	BUY	$20.0 - $27.43 $53,700 - $73,649	2,685 Added 11.95%	25,159 $630,000
Q2 2021 Aug 16, 2021	BUY	$24.34 - $38.34 $111,331 - $175,367	4,574 Added 25.55%	22,474 $604,000
Q1 2021 May 14, 2021	BUY	$24.74 - $40.2 $442,846 - $719,580	17,900 New	17,900 $509,000
Q3 2020 Nov 13, 2020	SELL	$18.07 - $31.84 $469,820 - $827,840	-26,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$20.1 - $24.69 $522,600 - $641,940	26,000 New	26,000 $546,000

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $54.9M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.